138 related articles for article (PubMed ID: 17580239)
1. Pediatrics: implementing the promise of early intervention for Fabry disease.
Raas-Rothschild A
Clin Ther; 2007; 29 Suppl A():S6. PubMed ID: 17580239
[No Abstract] [Full Text] [Related]
2. [Fabry disease: new clinical research--current therapeutic perspectives].
Beck M
Wien Klin Wochenschr; 2003 Apr; 115(7-8):215-7. PubMed ID: 12778772
[No Abstract] [Full Text] [Related]
3. Fabry disease in an oligosymptomatic male.
Altarescu G; Elstein D
Isr Med Assoc J; 2011 Mar; 13(3):191-2. PubMed ID: 21608346
[No Abstract] [Full Text] [Related]
4. Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease.
Lenders M; Brand E
J Am Soc Nephrol; 2018 Sep; 29(9):2265-2278. PubMed ID: 30093456
[No Abstract] [Full Text] [Related]
5. Paradoxical Response to Enzyme Replacement Therapy of Fabry Disease Cardiomyopathy.
Frustaci A; Russo MA; Chimenti C
Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27486136
[No Abstract] [Full Text] [Related]
6. Clinical trial for Fabry disease faces continuing hurdles.
Silversides A
CMAJ; 2009 Nov; 181(11):E251-2. PubMed ID: 19825933
[No Abstract] [Full Text] [Related]
7. Fabry disease: the need to stratify patient populations to better understand the outcome of enzyme replacement therapy.
Germain DP
Clin Ther; 2007; 29 Suppl A():S17-8. PubMed ID: 17580237
[No Abstract] [Full Text] [Related]
8. Enzyme replacement in Anderson-Fabry disease.
Bengtsson BA; Johansson JO; Hollak C; Linthorst G; FeldtRasmussen U
Lancet; 2003 Jan; 361(9354):352. PubMed ID: 12559898
[No Abstract] [Full Text] [Related]
9. [What is new in Fabry disease?].
Lidove O
Rev Med Interne; 2007 Dec; 28 Suppl 4():S296-7. PubMed ID: 17964003
[No Abstract] [Full Text] [Related]
10. Fabry disease--whom to treat and when.
Mehta A
Clin Ther; 2008; 30 Suppl B():S43-4. PubMed ID: 18395136
[No Abstract] [Full Text] [Related]
11. Fabry disease: a treatable lysosomal storage disorder.
Phadke SR; Mandal K; Girisha KM
Natl Med J India; 2009; 22(1):20-2. PubMed ID: 19761154
[TBL] [Abstract][Full Text] [Related]
12. Agalsidase beta (Fabrazyme) for Fabry disease.
Med Lett Drugs Ther; 2003 Sep; 45(1165):74-5. PubMed ID: 12968124
[No Abstract] [Full Text] [Related]
13. [CME. Fabry disease: rare but not to be missed].
Steinack C; Gaspert A; Kovacs R; Nowak A
Praxis (Bern 1994); 2015 Jul; 104(14):719-29. PubMed ID: 26135721
[No Abstract] [Full Text] [Related]
14. Early detection of Fabry disease: cardiac cases.
Weidemann F; Strotmann J
Clin Ther; 2008; 30 Suppl B():S46. PubMed ID: 18395138
[No Abstract] [Full Text] [Related]
15. Agalsidase: a second look. With hindsight: full data challenge efficacy.
Prescrire Int; 2003 Oct; 12(67):168-71. PubMed ID: 14619828
[No Abstract] [Full Text] [Related]
16. Enzyme therapy for Fabry's disease: registered for success?
Knebelmann B; Kurschat C; Thadhani R
Lancet; 2009 Dec; 374(9706):1950-1. PubMed ID: 19959220
[No Abstract] [Full Text] [Related]
17. Enzyme replacement therapy for Fabry's disease.
Deegan P
Lancet; 2010 May; 375(9725):1522-3; author reply 1523-4. PubMed ID: 20435224
[No Abstract] [Full Text] [Related]
18. Fabry disease: clinical outcomes of agalsidase enzyme replacement therapies.
Wanner C
Int J Clin Pract; 2007 Jul; 61(7):1234-5; author reply 1235. PubMed ID: 17577304
[No Abstract] [Full Text] [Related]
19. Enzyme replacement in Fabry disease: the essence is in the kidney.
Schiffmann R
Ann Intern Med; 2007 Jan; 146(2):142-4. PubMed ID: 17179053
[No Abstract] [Full Text] [Related]
20. Enzyme replacement therapy in Fabry disease: comparison of agalsidase alfa and agalsidase beta.
Mehta A; Beck M; Kampmann C; Frustaci A; Germain DP; Pastores GM; Sunder-Plassmann G
Mol Genet Metab; 2008; 95(1-2):114-5. PubMed ID: 18701330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
